| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 29 | 2023 | 706 | 3.300 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 11 | 2017 | 51 | 2.790 |
Why?
|
| Exosomes | 9 | 2020 | 101 | 2.480 |
Why?
|
| HIV Infections | 14 | 2022 | 2303 | 1.470 |
Why?
|
| Peptides | 7 | 2024 | 320 | 1.380 |
Why?
|
| Apoptosis | 17 | 2019 | 1398 | 1.250 |
Why?
|
| Receptors, CXCR4 | 9 | 2015 | 69 | 1.110 |
Why?
|
| HIV Envelope Protein gp120 | 10 | 2023 | 55 | 1.090 |
Why?
|
| Gene Products, nef | 6 | 2015 | 19 | 0.980 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 56 | 0.880 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 58 | 0.870 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2023 | 215 | 0.840 |
Why?
|
| Peptide Fragments | 5 | 2015 | 308 | 0.770 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 1502 | 0.710 |
Why?
|
| Extracellular Space | 3 | 2014 | 35 | 0.640 |
Why?
|
| Endothelium, Vascular | 5 | 2009 | 237 | 0.640 |
Why?
|
| Clusterin | 1 | 2017 | 9 | 0.590 |
Why?
|
| MicroRNAs | 3 | 2020 | 426 | 0.580 |
Why?
|
| Receptors, CCR5 | 4 | 2001 | 61 | 0.570 |
Why?
|
| Humans | 55 | 2024 | 37093 | 0.560 |
Why?
|
| Molecular Sequence Data | 14 | 2012 | 1568 | 0.520 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2013 | 47 | 0.510 |
Why?
|
| Cytokines | 2 | 2016 | 602 | 0.480 |
Why?
|
| Macrophages | 2 | 2020 | 439 | 0.450 |
Why?
|
| Momordica | 2 | 2023 | 14 | 0.440 |
Why?
|
| Amino Acid Sequence | 11 | 2012 | 1180 | 0.420 |
Why?
|
| Cell Line | 15 | 2019 | 1354 | 0.420 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 50 | 0.410 |
Why?
|
| Transfection | 8 | 2013 | 523 | 0.410 |
Why?
|
| HIV Seropositivity | 3 | 2022 | 190 | 0.390 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 357 | 0.380 |
Why?
|
| Cells, Cultured | 10 | 2016 | 1518 | 0.360 |
Why?
|
| Transport Vesicles | 1 | 2010 | 21 | 0.360 |
Why?
|
| Chemokine CXCL10 | 4 | 2015 | 37 | 0.350 |
Why?
|
| Models, Molecular | 2 | 2013 | 808 | 0.340 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.340 |
Why?
|
| Polymorphism, Genetic | 2 | 2001 | 191 | 0.340 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2001 | 72 | 0.330 |
Why?
|
| Virion | 4 | 2016 | 69 | 0.310 |
Why?
|
| Cell Proliferation | 4 | 2022 | 1198 | 0.300 |
Why?
|
| Protozoan Proteins | 2 | 2004 | 182 | 0.300 |
Why?
|
| Malaria, Cerebral | 3 | 2013 | 31 | 0.280 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 2231 | 0.280 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 91 | 0.270 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 102 | 0.270 |
Why?
|
| Jurkat Cells | 6 | 2010 | 79 | 0.250 |
Why?
|
| Biomedical Research | 4 | 2019 | 400 | 0.250 |
Why?
|
| Trypanosomiasis, African | 1 | 2004 | 23 | 0.230 |
Why?
|
| Vimentin | 2 | 2022 | 37 | 0.230 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 61 | 0.230 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2008 | 133 | 0.230 |
Why?
|
| Exons | 2 | 2001 | 88 | 0.230 |
Why?
|
| Endothelial Cells | 3 | 2013 | 308 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 201 | 0.220 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 75 | 0.220 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2004 | 83 | 0.210 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 68 | 0.210 |
Why?
|
| Mice | 13 | 2020 | 5913 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 211 | 0.210 |
Why?
|
| DNA, Viral | 6 | 2001 | 304 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2016 | 448 | 0.200 |
Why?
|
| Female | 13 | 2022 | 20969 | 0.200 |
Why?
|
| HLA Antigens | 1 | 2001 | 20 | 0.200 |
Why?
|
| Protein Transport | 3 | 2014 | 302 | 0.200 |
Why?
|
| Biofilms | 1 | 2024 | 168 | 0.200 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 21 | 0.200 |
Why?
|
| Animals | 20 | 2020 | 15081 | 0.200 |
Why?
|
| Brain | 3 | 2011 | 1346 | 0.200 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.190 |
Why?
|
| Cell Movement | 2 | 2022 | 571 | 0.190 |
Why?
|
| Gene Products, vpr | 1 | 2000 | 5 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 352 | 0.190 |
Why?
|
| Protein Kinase C | 1 | 2000 | 120 | 0.180 |
Why?
|
| Heterozygote | 1 | 1999 | 93 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 441 | 0.170 |
Why?
|
| Protein Binding | 2 | 2013 | 972 | 0.170 |
Why?
|
| Palmitic Acid | 1 | 2019 | 24 | 0.170 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1998 | 1 | 0.170 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 28 | 0.170 |
Why?
|
| Rural Population | 2 | 1999 | 294 | 0.160 |
Why?
|
| Stem Cells | 2 | 2020 | 141 | 0.160 |
Why?
|
| Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
| Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
| Simplexvirus | 4 | 1984 | 10 | 0.160 |
Why?
|
| RNA, Viral | 2 | 2015 | 301 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 290 | 0.160 |
Why?
|
| Gene Products, rev | 1 | 1997 | 4 | 0.160 |
Why?
|
| Antigens, CD34 | 2 | 2015 | 19 | 0.160 |
Why?
|
| Flow Cytometry | 3 | 2008 | 399 | 0.160 |
Why?
|
| Gene Expression | 2 | 2017 | 674 | 0.150 |
Why?
|
| Leptospirosis | 1 | 1997 | 25 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 1997 | 136 | 0.150 |
Why?
|
| HIV | 1 | 2017 | 98 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2019 | 1908 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2014 | 381 | 0.150 |
Why?
|
| Male | 13 | 2016 | 20025 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1996 | 103 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2017 | 859 | 0.140 |
Why?
|
| Drug Carriers | 1 | 2017 | 125 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 84 | 0.140 |
Why?
|
| Base Sequence | 7 | 1999 | 997 | 0.140 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.140 |
Why?
|
| Anti-HIV Agents | 2 | 2017 | 420 | 0.140 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 16 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2009 | 207 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 384 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 1609 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 73 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 121 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2015 | 513 | 0.130 |
Why?
|
| Heme | 1 | 2015 | 70 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 62 | 0.130 |
Why?
|
| Drug Resistance, Viral | 3 | 2005 | 63 | 0.130 |
Why?
|
| China | 1 | 2015 | 196 | 0.130 |
Why?
|
| Database Management Systems | 1 | 2014 | 19 | 0.130 |
Why?
|
| Qa-SNARE Proteins | 1 | 2014 | 9 | 0.130 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2014 | 9 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 408 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 306 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 1015 | 0.120 |
Why?
|
| Cyclosporine | 2 | 2005 | 27 | 0.120 |
Why?
|
| Parietal Cells, Gastric | 1 | 2014 | 19 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 127 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 177 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 2015 | 90 | 0.120 |
Why?
|
| United States | 4 | 2019 | 4223 | 0.120 |
Why?
|
| Mutation | 5 | 2010 | 1095 | 0.120 |
Why?
|
| Minority Groups | 1 | 2019 | 596 | 0.120 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 219 | 0.120 |
Why?
|
| Genotype | 3 | 2001 | 730 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 1999 | 578 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 105 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 1993 | 9 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1207 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2015 | 150 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 161 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 291 | 0.110 |
Why?
|
| Genes, myc | 1 | 1993 | 29 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 186 | 0.110 |
Why?
|
| Chemokine CXCL12 | 3 | 2009 | 29 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2012 | 20 | 0.110 |
Why?
|
| Software | 1 | 2014 | 217 | 0.110 |
Why?
|
| Chemokine CCL5 | 3 | 2007 | 39 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2012 | 265 | 0.110 |
Why?
|
| Healthcare Disparities | 2 | 2008 | 494 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.110 |
Why?
|
| Antimalarials | 1 | 2013 | 55 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2005 | 234 | 0.110 |
Why?
|
| Computational Biology | 1 | 2014 | 293 | 0.100 |
Why?
|
| Haplotypes | 1 | 2013 | 182 | 0.100 |
Why?
|
| Static Electricity | 1 | 2012 | 78 | 0.100 |
Why?
|
| Cell Fusion | 4 | 1984 | 19 | 0.100 |
Why?
|
| Entamoeba | 1 | 1992 | 3 | 0.100 |
Why?
|
| Molecular Epidemiology | 2 | 2003 | 50 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 92 | 0.100 |
Why?
|
| Genome, Human | 1 | 2013 | 135 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 409 | 0.100 |
Why?
|
| Neuroglia | 2 | 2013 | 124 | 0.100 |
Why?
|
| Adult | 6 | 2015 | 11712 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 78 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 183 | 0.100 |
Why?
|
| Speech Acoustics | 1 | 2011 | 1 | 0.100 |
Why?
|
| Deafness | 1 | 2011 | 7 | 0.100 |
Why?
|
| Telephone | 1 | 2011 | 34 | 0.100 |
Why?
|
| Speech Perception | 1 | 2011 | 13 | 0.100 |
Why?
|
| Amino Acids | 1 | 2012 | 145 | 0.100 |
Why?
|
| Research | 1 | 2012 | 163 | 0.100 |
Why?
|
| Thermodynamics | 1 | 2012 | 216 | 0.100 |
Why?
|
| HIV-2 | 2 | 2004 | 9 | 0.100 |
Why?
|
| Prevalence | 1 | 2015 | 1455 | 0.100 |
Why?
|
| Genomics | 1 | 2013 | 223 | 0.100 |
Why?
|
| Plasmodium berghei | 1 | 2011 | 30 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 133 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2011 | 75 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2011 | 89 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 76 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2014 | 1492 | 0.090 |
Why?
|
| DNA | 2 | 1998 | 574 | 0.090 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.090 |
Why?
|
| Chemokines, CXC | 2 | 2000 | 35 | 0.090 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.090 |
Why?
|
| Choroidal Neovascularization | 1 | 2009 | 4 | 0.090 |
Why?
|
| Angiogenic Proteins | 1 | 2009 | 7 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 730 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2009 | 15 | 0.090 |
Why?
|
| Language | 1 | 2011 | 157 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2379 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 70 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2009 | 30 | 0.080 |
Why?
|
| Caspases | 2 | 2013 | 147 | 0.080 |
Why?
|
| Ligands | 2 | 2000 | 349 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 295 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 935 | 0.080 |
Why?
|
| Middle Aged | 4 | 2015 | 10129 | 0.080 |
Why?
|
| Infant | 3 | 2007 | 1046 | 0.080 |
Why?
|
| Phylogeny | 3 | 2003 | 644 | 0.080 |
Why?
|
| HIV Antibodies | 1 | 1988 | 30 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 767 | 0.080 |
Why?
|
| Porphyromonas gingivalis | 2 | 1999 | 32 | 0.080 |
Why?
|
| DNA Transposable Elements | 2 | 1999 | 48 | 0.080 |
Why?
|
| Aged | 3 | 2015 | 6741 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 5363 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 269 | 0.080 |
Why?
|
| Georgia | 2 | 1999 | 174 | 0.080 |
Why?
|
| Interinstitutional Relations | 1 | 2008 | 38 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 35 | 0.080 |
Why?
|
| Young Adult | 2 | 2015 | 4268 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2008 | 111 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 661 | 0.080 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 21 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 189 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 1371 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 81 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 135 | 0.070 |
Why?
|
| Recombination, Genetic | 2 | 2004 | 93 | 0.070 |
Why?
|
| Temperature | 3 | 2004 | 286 | 0.070 |
Why?
|
| Genes, Viral | 2 | 1982 | 63 | 0.070 |
Why?
|
| Cytopathogenic Effect, Viral | 3 | 1982 | 13 | 0.070 |
Why?
|
| Genes, nef | 1 | 2005 | 5 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2015 | 1418 | 0.060 |
Why?
|
| Disease Progression | 2 | 2015 | 601 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 37 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 90 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 1 | 2005 | 59 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 448 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2004 | 59 | 0.060 |
Why?
|
| Cerebellum | 1 | 2004 | 73 | 0.060 |
Why?
|
| Brain Stem | 1 | 2004 | 50 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2004 | 102 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 1984 | 82 | 0.060 |
Why?
|
| Barbados | 2 | 2003 | 3 | 0.050 |
Why?
|
| Plant Proteins | 1 | 2023 | 93 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 259 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 3483 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2001 | 17 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 1997 | 2026 | 0.050 |
Why?
|
| Child | 3 | 2015 | 3131 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2022 | 157 | 0.050 |
Why?
|
| Hela Cells | 2 | 2004 | 366 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2000 | 8 | 0.050 |
Why?
|
| Genes, pol | 1 | 2000 | 15 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 260 | 0.050 |
Why?
|
| Sphingosine | 1 | 2000 | 21 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 43 | 0.050 |
Why?
|
| Neurons | 2 | 2015 | 1175 | 0.050 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 7 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 60 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2000 | 51 | 0.050 |
Why?
|
| Necrosis | 1 | 2000 | 49 | 0.050 |
Why?
|
| Hindlimb | 1 | 2020 | 27 | 0.050 |
Why?
|
| Ischemia | 1 | 2020 | 46 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 1999 | 19 | 0.040 |
Why?
|
| Hemagglutinins | 1 | 1999 | 9 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1999 | 16 | 0.040 |
Why?
|
| Rabbits | 2 | 2014 | 283 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 1999 | 20 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1999 | 111 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 444 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 935 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 286 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 59 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2013 | 162 | 0.040 |
Why?
|
| DNA Fingerprinting | 1 | 1998 | 18 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 80 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 372 | 0.040 |
Why?
|
| Homozygote | 1 | 1998 | 77 | 0.040 |
Why?
|
| Ghana | 2 | 2007 | 32 | 0.040 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 3 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1997 | 29 | 0.040 |
Why?
|
| Luciferases | 1 | 1997 | 63 | 0.040 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 53 | 0.040 |
Why?
|
| Research Personnel | 1 | 2019 | 155 | 0.040 |
Why?
|
| Leptospira | 1 | 1997 | 22 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 169 | 0.040 |
Why?
|
| Astrocytes | 1 | 2000 | 255 | 0.040 |
Why?
|
| Pregnancy | 2 | 1996 | 1549 | 0.040 |
Why?
|
| Homosexuality | 1 | 1997 | 36 | 0.040 |
Why?
|
| Viral Proteins | 3 | 1984 | 174 | 0.040 |
Why?
|
| Morphine | 1 | 2017 | 85 | 0.040 |
Why?
|
| Virus Replication | 3 | 2008 | 278 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 217 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1997 | 215 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1039 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 110 | 0.040 |
Why?
|
| Heterosexuality | 1 | 1997 | 88 | 0.040 |
Why?
|
| Hippocampus | 1 | 2000 | 561 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 121 | 0.030 |
Why?
|
| Cell Count | 2 | 2013 | 135 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 186 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 7 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 28 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 46 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 37 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1997 | 435 | 0.030 |
Why?
|
| Methamphetamine | 1 | 2017 | 159 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 122 | 0.030 |
Why?
|
| Time Factors | 1 | 2000 | 1742 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2009 | 106 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 1618 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 84 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Cocaine | 1 | 2017 | 232 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2014 | 62 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 219 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 2005 | 59 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 312 | 0.030 |
Why?
|
| MyoD Protein | 1 | 1993 | 9 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1993 | 17 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1993 | 59 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1993 | 26 | 0.030 |
Why?
|
| Heptanoic Acids | 1 | 2013 | 12 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 1996 | 894 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 129 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 51 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1993 | 51 | 0.030 |
Why?
|
| Artemisinins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Pyrroles | 1 | 2013 | 55 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1993 | 143 | 0.030 |
Why?
|
| Leukocytes | 1 | 2013 | 72 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2013 | 141 | 0.030 |
Why?
|
| Actins | 1 | 1993 | 148 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1130 | 0.030 |
Why?
|
| Kinetics | 3 | 1987 | 708 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 1993 | 129 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 146 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 1992 | 7 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 502 | 0.030 |
Why?
|
| Phonetics | 1 | 2011 | 4 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 928 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1993 | 366 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 66 | 0.020 |
Why?
|
| RNA | 1 | 1993 | 241 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2009 | 5 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2009 | 11 | 0.020 |
Why?
|
| Injections | 1 | 2009 | 35 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 60 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 465 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 539 | 0.020 |
Why?
|
| Risk Factors | 1 | 1997 | 3562 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 517 | 0.020 |
Why?
|
| Nigeria | 1 | 1988 | 86 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 95 | 0.020 |
Why?
|
| Canada | 1 | 1988 | 130 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 1987 | 4 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1987 | 25 | 0.020 |
Why?
|
| E-Selectin | 1 | 2007 | 21 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 14 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 259 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 60 | 0.020 |
Why?
|
| Adenine Phosphoribosyltransferase | 1 | 1987 | 1 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 176 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1987 | 7 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2007 | 51 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 61 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1987 | 41 | 0.020 |
Why?
|
| Health Services Research | 1 | 2008 | 148 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 311 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 446 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1984 | 325 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 217 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 356 | 0.020 |
Why?
|
| Chimera | 1 | 2005 | 15 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 739 | 0.020 |
Why?
|
| Cyclophilin A | 1 | 2004 | 15 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 201 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1984 | 142 | 0.010 |
Why?
|
| HIV Protease | 1 | 2003 | 21 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2003 | 33 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1982 | 12 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 474 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 387 | 0.010 |
Why?
|
| Virulence | 1 | 1999 | 223 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1987 | 10 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 238 | 0.000 |
Why?
|
| Plasmids | 1 | 1987 | 246 | 0.000 |
Why?
|
| Chickens | 1 | 1987 | 133 | 0.000 |
Why?
|